Bortezomib and hyponatraemia Patient Reports February 12, 2012

Bortezomib Side Effects Report #5931248-2
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2008. Male patient, weighting 154.3 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: dehydration, hyponatraemia, hypophagia, nausea . Bortezomib dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #4642356-0
Bortezomib side effect was reported by a Physician from on Apr 20, 2005. Female patient, weighting 124.0 lb, was diagnosed with cervix carcinoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: confusional state, fatigue, hypokalaemia, hyponatraemia, thrombocytopenia. Bortezomib dosage: 1.35 MG/M2 D1,4,8,1 1 Q21D INTRAVENOUS. During the same period patient was treated with IRINOTECAN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #4633802-7
Bortezomib side effect was reported by a Physician from on Apr 12, 2005. Female patient, weighting 124.0 lb, was diagnosed with cervix cancer metastatic and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: confusional state, disease progression, fatigue, hypokalaemia, hyponatraemia, thrombocytopenia. Bortezomib dosage: 1.35 MG/M2 D1, 4,8, 11 Q12D INTRAVENOUS. During the same period patient was treated with IRINOTECAN PFIZER, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5968754-0
Bortezomib side effect was reported by a Physician from UNITED STATES on Nov 25, 2008. Male patient, weighting 119.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: asthenia, dyskinesia, dysstasia, hypoaesthesia, hyponatraemia, neuralgia, paraesthesia, peripheral sensory neuropathy. Bortezomib dosage: 1.3MG/M2/DAY DAYS 1, 4, 8, 11 IV (4 DOSES). During the same period patient was treated with BACTRIM, FLUCONAZOLE, MEROPENEM, PANTOPRAZOLE, ZOFRAN. Patient was hospitalized. Patient recovered.